
Updates
Shares of DNA testing firm 23andMe ME.O rise 2% to $1.50 in extended trading
Special committee unanimously rejects CEO Anne Wojcicki's acquisition proposal
ME's CEO Anne Wojcicki had offered to buy the remaining stake in the company for $0.41/shr, or about $11 mln
Wojcicki said private equity firm New Mountain is no longer interested in acquiring ME
Last month, Wojcicki and New Mountain Capital had offered to take the company private for $2.53 per share, valuing the company at $67.9 million
As of last close, stock down 54.7% YTD